MicroPort Neuro (“the Company”) reported to the Hong Kong Stock Exchange that on 13 May 2026 it repurchased 100,000 ordinary shares on-market, paying between HKD 9.85 and HKD 9.90 per share. The volume-weighted average price was HKD 9.8653, bringing the total consideration to HKD 0.99 million.
Following the transaction, the number of issued shares (excluding treasury shares) fell by 0.02 % to 575.37 million. Treasury shares rose correspondingly to 9.66 million, while the Company’s total issued share capital remained unchanged at 585.03 million shares.
The repurchased stock is being held as treasury shares; no cancellations were reported. Under the repurchase mandate approved on 27 June 2025, MicroPort Neuro may buy back up to 57.55 million shares. To date, 0.60 million shares—equivalent to 0.10 % of the mandate’s reference share base—have been repurchased.
Pursuant to Hong Kong listing rules, a moratorium is in place prohibiting new share issues or sales of treasury shares until 12 June 2026. The Company confirmed that the repurchases complied with all applicable regulations and that no material changes have been made to the previously filed explanatory statement.
Comments